58.9 F
New York
Wednesday, April 21, 2021
Home Healthcare

Healthcare

Healthcare company and market news.

The pharmaceutical division of Johnson & Johnson recently reported on its early vaccine trials against the novel coronavirus. The giant corporation randomly assigned adults between 18 years of age and 55 years of age, as well as another study of 65-year-olds and older. The subjects in the...
The Centers for Disease Control is contemplating reducing its recommendation for individuals who come into contact with people who test positive for COVID-19. The current recommendation is 14 days, but the CDC is considering the possibility that the time could be reduced to a week. 
Health workers across the country will be the first Americans to be vaccinated against the novel coronavirus. But, employees from essential government agencies will be next to get the COVID vaccine once it’s approved. Some government sources say that the vaccine could be distributed in as little...
One of the biggest questions everyone has about the coronavirus may finally have an answer. The question is how long is someone protected against re-infection of COVID-19 once they’ve been infected the first time? The answer, according to one study, could be for at least six months.
AstraZeneca shares dropped more than 6 percent during after-hours trading on Tuesday evening. The fall in shares occurred after the company announced that it was pausing it’s late-stage coronavirus vaccine trial because of safety concerns. The pharmaceutical company released a statement saying, “This is...
On Sunday, President Trump announced that the Food and Drug Administration (FDA) has approved the use of convalescent plasma in COVID-19 patients. The FDA approved the plasma product as an emergency use for novel coronavirus patients. The president called the news a “historic breakthrough”...
The FDA has approved a heart pump to treat COVID-19 patients who have severe heart and lung failure. The approval was an emergency measure to use the Impella heart pump made by Abiomed. The heart pump works with an oxygen machine to treat coronavirus patients with specific...
Eastman Kodak stock skyrocketed this week after President Trump announced a deal to have the historical photography company make generic ingredients. Shares for Kodak were up by over 2700 percent at one point this week on the news. The NYSE halted trading several times due to the...
According to researchers at the University of Michigan, an immune suppressant drug called tocilizumab may help treat COVID-19 related cytokine storm. The medication, generally prescribed to rheumatoid arthritis patients, was found to reduce mortality in some severely ill coronavirus patients.  The sickest COVID-19 patients...
Gilead Sciences, the drugmaker for remdesivir, the promising new coronavirus treatment, has announced that it will begin charging for the drug in July. The pharmaceutical company had been donating some of the medication for government distribution since May when it received emergency authorization use.